FDA Warns Another Eye Product Could Be Contaminated With Bacteria Amid Outbreak Of Infections

  • The FDA recommended the initial recall for the artificial tears due to Global Pharma’s good manufacturing practice violations, including lack of appropriate microbial testing, formulation issues, and lack of proper controls concerning tamper-evident packaging.
  • “Using contaminated artificial tears increases risk of eye infections that could result in blindness or death,” the FDA said.
  • “Patients who have signs or symptoms of an eye infection should talk to their health care provider or seek medical care immediately.”